Sort
51,593 grants matching “hepatitis”
RBP2 Biology and Pathobiology
$682,891William S Blaner · Columbia University Health Sciences · R01 · FY2023 · DK
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs
$682,769Richard S Garfein · University Of California, San Diego · R01 · FY2014 · DA
Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)
$682,721William Robert Jarnagin · Sloan-Kettering Inst Can Research · U01 · FY2020 · CA
Predicting post-transplant mortality and global functional health based on pre-transplant functional status in liver transplantation
$682,697Jennifer C. Lai · University Of California, San Francisco · R01 · FY2019 · AG
HEPATITIS C VIRUS REPLICATION AND LIVER INJURY
$682,509University Of Washington · U19 · FY2002 · AI
Asprosin, body weight, and risk of type 2 diabetes in U.S. men and women
$682,457Simin Liu · Brown University · R01 · FY2021 · DK
Psychoeducation for HCV and Alcohol Behaviors
$682,443Carol S North · Ut Southwestern Medical Center · R01 · FY2008 · AA
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B
$682,265Stewart Cooper · California Pacific Med Ctr Res Institute · R01 · FY2020 · DK
Project ACCESS: Advancing Equitable Access to HIV/HCV Testing Through Structural Transformation in Syringe Services Programs: A Cluster Randomized Trial
$682,201Tyler Scott Bartholomew · University Of Miami School Of Medicine · R01 · FY2024 · DA
Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers
$682,158Luke Norton · University Of Texas Hlth Science Center · R01 · FY2023 · DK
Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers
$682,154Luke Norton · University Of Texas Hlth Science Center · R01 · FY2025 · DK
Sickle Cell Disease and Sickle Cell Trait Protection Against HIV-1-infection in Africans and African Americans
$682,111Sergei Nekhai · Howard University · R01 · FY2024 · HL
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$682,029Ranganath Muniyappa · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
NEW PROBE AND METHODS FOR CORRELATED LM AND EM
$682,000Roger Y Tsien · University Of California, San Diego · R01 · FY2012 · GM
Randomized Trial of Ibudilast for Methamphetamine Dependence
$681,986Keith Gregory Heinzerling · University Of California Los Angeles · R01 · FY2012 · DA
Epidemiology of Helicobacter Pylori Transmission
$681,962Julie Parsonnet · Stanford University · R01 · FY2008 · AI
Dietary Regulation of Intestinal Inflammation and Repair
$681,939David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · DK
Dietary Regulation of Intestinal Inflammation and Repair
$681,939David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DK
Dietary Regulation of Intestinal Inflammation and Repair
$681,939David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · DK
Multidisciplinary Studies of Lymphoma
$681,891Patricia Hartge · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Technology Core - The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)
$681,849Sally M McFall · Northwestern University · U54 · FY2025 · EB
AIDS Clinical Trial Group Laboratory Center
$681,736Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2025 · AI
Cholesterol toxicity in alcohol-associated hepatitis
$681,678Zhenghui Gordon Jiang · Beth Israel Deaconess Medical Center · R01 · FY2025 · AA
The PRIORITY Study: from PRedIctiOn to pReventIon of youth-onset TYpe 2 diabetes
$681,677Sheela Natesh Magge · Johns Hopkins University · U01 · FY2025 · DK
Project 1: Perturbation of Pre-Existing Immunity to Chronic Viral Infection Through Immunotherapy
$681,634Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2021 · AI